SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy's Laboratories earmarks capex of around Rs 1,000 crore for current fiscal

24 May 2021 Evaluate

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond. The Hyderabad based firm invested about Rs 1,000 crore in the 2020-21 fiscal.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Labs. Share Price

1362.60 -13.70 (-1.00%)
30-Jun-2026 12:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.45
Dr. Reddys Labs. 1362.60
Cipla 1469.05
Zydus Lifesciences 1122.00
Lupin 2414.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: